CMS Proposes Policies That Could Hike Pay For CAR-T Cancer Drug

By John Wilkerson / April 23, 2019 at 8:53 PM
CMS proposed Tuesday (April 23) policy changes that would significantly increase Medicare pay to hospitals for administering expensive CAR-T cancer drugs and make it easier for hospitals to get the maximum possible reimbursement for administering the chimeric antigen receptor T-cell therapies. The agency says there isn’t enough data yet to create a hospital billing code for CAR-T, but Verma implied CMS wants to quickly create a MS-DRG for the procedure once there are sufficient data on which to set the...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.